DM
DGX icon

Deerfield Management’s Quest Diagnostics DGX Stock Holding History

Deerfield Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,392
Closed -$3.19M – 107
2025
Q4 		$3.19M Buy
+18,392
New +$3.35M 0.04% 77
2024
Q2 		– Sell
-2,157
Closed -$287K – 470
2024
Q1 		$287K Buy
+2,157
New +$280K 0.01% 267
2014
Q2 		– Sell
-440,303
Closed -$25.5M – 133
2014
Q1 		$25.5M Buy
+440,303
New +$23.6M 1.04% 36

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Deerfield Management's DGX Position: Q1 2026 in Review

Deerfield Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 18,392 shares — an estimated $3.19M sold.

Deerfield Management first reported a position in DGX in Q1 2014 and held it in 3 quarters. The position peaked at $25.5M in Q1 2014. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Deerfield Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 18,392 Quest Diagnostics shares in Q1 2026, an estimated $3.19M.
  • Deerfield Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 3 quarters.
  • Deerfield Management's Quest Diagnostics position peaked at $25.5M in Q1 2014.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.